Customized Stability Studies
As part of a comprehensive CMC program offering, RCI offers ICH-compliant stability studies for both drug substance and drug product candidates. Further, we have extensive experience developing R&D-based (non-ICH compliant) stability studies for important intermediates in the life science space or final products with non-life science applications (i.e. coatings, stabilizers, dyes). Please contact us to discuss the type of stability study that is optimal for your new product!
Chief Commercial Officer
Richman Chemical Inc.
P: 215-628-4632, x-13
Click here to see all of Richman Chemical's newsletters.